Guerbet (GBT) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
13 Jun, 2025Executive summary
H1 2024 revenue reached €419.2m, up 11.8% at constant exchange rates, with growth across all activities and regions.
Restated EBITDA margin improved to 15.4% from 12.7% a year earlier; operating income nearly tripled to €30.3m.
Net income rose to €10.0m from €1.3m in H1 2023, despite higher financial and tax expenses.
Financial highlights
Revenue increased 10.7% year-over-year to €419.2m; at CER, growth was 11.8%.
EBITDA rose 32.9% to €61.0m, with a margin of 14.6% of revenue.
Operating income reached €30.3m (7.2% of revenue), up from €10.3m (2.7%) in H1 2023.
Net debt was €364.9m, with a net debt/EBITDA ratio of 3.2x, improved from 3.5x a year earlier.
Free cash flow was negative at -€29.1m, a significant improvement from -€72.0m in H1 2023.
Outlook and guidance
2024 revenue growth now expected to exceed 9% like-for-like and at CER, up from >8% previously.
Adjusted EBITDA margin rate forecast to surpass 2021's 14.4%.
Free cash flow expected to be positive for the full year.
Latest events from Guerbet
- Net loss of €112.7 million driven by impairment, with 2026 outlook negatively impacted by Raleigh site.GBT
H2 202511 Mar 2026 - 2025 revenue fell 3.5% at CER, but EBITDA margin and cash flow outlooks remain positive.GBT
Q4 2025 TU5 Feb 2026 - Q3 2025 marked a return to growth, led by Elucirem™ and LipiodolⓇ momentum.GBT
Q3 2025 TU23 Oct 2025 - Revenue and profit declined in H1 2025, leading to lower guidance and cost focus.GBT
H1 202525 Sep 2025 - H1 revenue fell 5.4% at CER, but double-digit growth is expected in H2 as France recovers.GBT
Q2 2025 TU24 Jul 2025 - Revenue up 8.1% to €620.5m, driven by Americas and Asia, with 2024 growth above 9% expected.GBT
Q3 2024 TU13 Jun 2025 - H1 2024 revenue up 11.8% at CER, with 2024 growth and margin guidance reaffirmed.GBT
Q2 2024 TU13 Jun 2025 - Q1 2025 revenue declined 7.3%, but annual growth and margin targets remain on track.GBT
Q1 2025 TU6 Jun 2025 - 2024 revenue rose 9% like-for-like, with strong Americas and Asia growth and improved margins.GBT
Q4 2024 TU6 Jun 2025